Doppler Imaging and Morbidly Adherent Placenta

Antepartum Hemorrhage Clinical Trial

Official title:

The Role of Grey Scale Ultrasound, 2D, and 3D Power Doppler in Diagnosing and Predicting the Surgical Risks in Patients With Morbidly Adherent Placenta.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03267446
• Other study ID #: CU28817
• Status: Recruiting
• Phase: N/A
• First received: August 29, 2017
• Last updated: August 29, 2017
• Start date: August 29, 2017
• Est. completion date: September 1, 2018

Study information

• Verified date: August 2017
• Source: Cairo University
• Contact: Ahmed M Hussein, MD
• Phone: 01223 515652
• Email: ahmed_mhussein[@]live.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is to assess the value of adding 3D power Doppler (as a diagnostic technique) to gray scale technique in the antenatal diagnosis of morbidly adherent placenta as well as predict the surgical outcome regarding the type of surgery and the intra operative morbidities.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Est. completion date: September 1, 2018
• Est. primary completion date: September 1, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• Age: 18 - 45.

• Pregnant 32 weeks or more.

• Placenta previa (Major and Minor).

• History of previous cesarean section.

Exclusion Criteria:

• Medical disorders such as bleeding disorders.

• Lethal fetal anomalies.

• Delivery before 34 weeks.

Related Conditions & MeSH terms

• Antepartum Hemorrhage
• Hemorrhage

Intervention

Device:
• 3D Doppler Ultrasound
3D volumes will be obtained in automatic sweeps using a motorized curved-array transducer while the women held their breath. In order to interpret the data consistently, the settings of power, On Voluson E10; GE Medical Systems)

Locations

Country	Name	City	State
Egypt	Kasr el aini hospital	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Sensitivity of 3D power Doppler in detecting morbidly adherent placenta.		12 months